Roivant Sciences (ROIV) Financials

$34.18

$-0.34 (-0.98%)

As on 02-Sep-2026 16:00EDT

Market cap

$25,072 Mln

Revenue (TTM)

$8 Mln

P/E Ratio

--

P/B Ratio

6.4

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Cash From Operating Activities	--	-750.35	-839.45	-765.27	-843.39	-677.73
Cash Flow from Investing Activities	--	-682.33	-1,766.29	5,203.62	-44.27	303.30
Cash from Financing Activities	--	134.24	-1,219.79	419.36	499.46	306.79
Net Cash Inflow / Outflow	--	--	--	--	-388.20	-67.64

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Adjusted EPS ($)	-0.44	-0.37	-0.24	5.42	-1.36	-1.22
Cash EPS ($)	--	-0.36	-0.22	5.44	-1.33	-1.21
Adjusted Book Value ($)	--	5.57	6.63	7.43	1.56	2.39
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.92	-1.19	-0.95	-1.14	-0.98
Free Cash Flow per Share ($)	--	-0.93	-1.19	-0.95	-1.15	-1.00

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
ROCE (%)	--	-6.36	-3.06	107.28	-56.37	-41.40
ROE (%)	-2.77	-6.51	-3.23	122.05	-71.70	-47.56
ROA (%)	-4.96	-5.37	-2.72	90.49	-40.57	-32.05
EBIT Margin (%)	-3,848.65	-3,203.12	-2,346.02	14,069.74	-2,718.12	-1,658.12
Net Margin (%)	-3,534.88	-3,629.19	-591.96	13,294.18	-1,146.85	2,385.05
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Revenue Growth (%)	-67.58	-0.72	-0.11	0.04	-0.43	1.32
EBIT Growth (%)	68.87	61.18	-114.81	637.05	6.51	-2.34
Net Profit Growth (%)	59.78	-74.30	-103.95	531.00	-19.37	-4.45
EPS Growth (%)	37.24	-0.52	-1.04	4.99	-0.11	-0.03
Book Value Growth (%)	-8.10	--	--	--	--	--

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Price / Earnings	--	-75.06	-41.50	1.95	-5.43	-4.05
Price / Book Value	6.42	4.97	1.52	1.42	4.73	2.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.74	-70.10	-3.52	0.52	-5.11	-1.79
Close Price ($)	35.39	27.70	10.09	10.54	7.38	4.94
High Price ($)	35.90	30.33	13.06	13.24	10.00	16.76
Low Price ($)	10.71	8.73	9.92	6.97	2.52	4.51
Market Cap ($ Cr)	25,071.83	--	--	--	--	--

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debt to Equity	--	0.02	0.02	0.08	0.42	0.17
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.05	0.01
Current Ratio	16.72	18.37	33.47	25.24	6.60	11.64
Quick Ratio	16.72	--	--	25.10	6.59	11.73
Interest Coverage	--	--	--	132.34	-30.64	-130.20

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17
Debtors to sales (%)	10,531.43	9,562.17	--	253.15	119.39	12.18
Asset Turnover	0.00	0.00	0.00	0.01	0.01	0.02
Receivable days	--	34,925.82	1,041.11	672.47	257.03	67.93
Inventory Days	--	--	14,133.29	4,341.43	-824.76	965.59
Payable days	--	5,925.44	15,419.08	10,399.57	4,358.74	1,122.98
Cash Conversion Cycle	--	--	-244.68	-5,385.68	-4,926.47	-89.46

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.